Literature DB >> 9512943

A study on the route of 1-methylurate formation in theophylline metabolism.

C Bayar1, I Ozer.   

Abstract

The urinary excretion patterns of theophylline metabolites were studied in a subject on a routine, oral dose of 600 mg/day. The highest correlation was observed between the excretions of 1,3-dimethylurate and 1-methylurate (r = 0.73 +/- 0.08). The poorest correlations were observed when the excretion of 1-methylxanthine was compared to those of 1-methylurate and 1,3-dimethylurate (r < or = 0.55, P > or = 0.05). The difference in the quality of the correlations was not due to rate-limiting or class-specific carries. The results suggested that 1-methylurate did not derive solely from 1-methylxanthine, implicating 1,3-dimethylurate as an alternative source. When the theophylline regimen was supplemented by a single dose of caffeine (4.80 mg/kg), the recovery of unaltered caffeine and the yield of metabolites arising from the primary 3-demethylation of caffeine (1-methylxanthine, 7-methylxanthine, 1-methylurate, 1,7-dimethylxanthine and 1,7-dimethylurate) were found to be unchanged. The lack of competition between caffeine and theophylline indicated that caffeine 3-demethylation and the demethylations of theophylline are not catalyzed by the same cytochrome P450 system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9512943     DOI: 10.1007/BF03190979

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  The influence of caffeine on the steady-state pharmacokinetics of theophylline.

Authors:  J H Jonkman; F A Sollie; R Sauter; V W Steinijans
Journal:  Clin Pharmacol Ther       Date:  1991-03       Impact factor: 6.875

2.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

4.  Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.

Authors:  A Lelo; G Kjellen; D J Birkett; J O Miners
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

5.  A kinetic analysis of coupled enzyme assays.

Authors:  W R McClure
Journal:  Biochemistry       Date:  1969-07       Impact factor: 3.162

6.  Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.

Authors:  F Berthou; J P Flinois; D Ratanasavanh; P Beaune; C Riche; A Guillouzo
Journal:  Drug Metab Dispos       Date:  1991 May-Jun       Impact factor: 3.922

7.  Variability in caffeine metabolism.

Authors:  D M Grant; B K Tang; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

8.  1-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.

Authors:  D J Birkett; J O Miners; R O Day
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

9.  Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid.

Authors:  D J Birkett; J O Miners; J Attwood
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

10.  Characterisation of theophylline metabolism in human liver microsomes.

Authors:  R A Robson; A P Matthews; J O Miners; M E McManus; U A Meyer; P M Hall; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

View more
  2 in total

1.  Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality.

Authors:  Johannes Raffler; Nele Friedrich; Matthias Arnold; Tim Kacprowski; Rico Rueedi; Elisabeth Altmaier; Sven Bergmann; Kathrin Budde; Christian Gieger; Georg Homuth; Maik Pietzner; Werner Römisch-Margl; Konstantin Strauch; Henry Völzke; Melanie Waldenberger; Henri Wallaschofski; Matthias Nauck; Uwe Völker; Gabi Kastenmüller; Karsten Suhre
Journal:  PLoS Genet       Date:  2015-09-09       Impact factor: 5.917

2.  Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing.

Authors:  Daniel J Wilkinson; Giovanny Rodriguez-Blanco; Warwick B Dunn; Bethan E Phillips; John P Williams; Paul L Greenhaff; Kenneth Smith; Iain J Gallagher; Philip J Atherton
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.